Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue
- PMID: 8512063
- DOI: 10.1006/abio.1993.1197
Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue
Abstract
Conditions for specific interaction between Alcian blue and proteoglycans were optimized by comparing the differential spectra of Alcian blue obtained with purified chondroitin sulfate dissolved in water with the spectra obtained with nasal cartilage proteoglycans dissolved in synovial fluid. A method was then designed that provides specific precipitation of proteoglycans or glycosaminoglycans in 4 M guanidine - HCl in the presence of protein, hyaluronic acid, or nucleic acids. The specificity is achieved by using a low pH in combination with detergent and high salt concentration. Stepwise addition of reagents is necessary to avoid binding of Alcian blue to proteins and nucleic acids. All polyanions, except polysulfates, are first neutralized by lowering the pH to 1.5. By including detergent in this step, the hydrophobic protein regions are blocked and not accessible for binding with the dye. These regions could otherwise bind Alcian blue by hydrophobic interaction. When the Alcian blue reagent is added after, only the polysulfated molecules will remain charged and free to interact with Alcian blue. At least 0.4 M guanidine-HCl is required to abolish the negative interference by proteins. All sulfated glycosaminoglycans are precipitated at 0.4 M guanidine-HCl. With increasing guanidine-HCl concentrations, the different glycosaminoglycans are precipitated in accordance with the critical electrolyte concentration of the respective glycosaminoglycan. The Alcian blue precipitation can be performed at different concentrations of guanidine-HCl in order to separate different classes of proteoglycans. Excess dye and contaminating proteins are removed by a wash in a DMSO-MgCl2 solution and the precipitate is dissolved in a mixture of guanidine-HCl and propanol. For quantitation, the absorbance is recorded in a microplate reader with the 600-nm filter, the assay being linear between 0.5 and 20 micrograms proteoglycan. Since no digestion of samples with protease is needed, the proteoglycans are recovered in native form. The proteoglycan-Alcian blue complexes dissociate in the guanidine-HCl/propanol mixture and the proteoglycans can be selectively precipitated with propanol. The dye is used for quantitation and the proteoglycans can be utilized for further analysis.
Similar articles
-
Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.Anal Biochem. 1998 Feb 15;256(2):229-37. doi: 10.1006/abio.1997.2494. Anal Biochem. 1998. PMID: 9473282
-
Size-dependent separation of proteoglycans by electrophoresis in gels of pure agarose.Anal Biochem. 1993 May 1;210(2):292-8. doi: 10.1006/abio.1993.1198. Anal Biochem. 1993. PMID: 8512064
-
Differential use of Alcian blue and toluidine blue dyes for the quantification and isolation of anionic glycoconjugates from cell cultures: application to proteoglycans and a high-molecular-weight glycoprotein synthesized by articular chondrocytes.Anal Biochem. 2000 Oct 15;285(2):211-9. doi: 10.1006/abio.2000.4761. Anal Biochem. 2000. PMID: 11017704
-
Alcian blue. Now you see it, now you don't.Eur J Oral Sci. 1996 Feb;104(1):2-9. doi: 10.1111/j.1600-0722.1996.tb00038.x. Eur J Oral Sci. 1996. PMID: 8653492 Review.
-
Application of cationic probes for the ultrastructural localization of proteoglycans in basement membranes.Microsc Res Tech. 1994 Jun 1;28(2):125-40. doi: 10.1002/jemt.1070280204. Microsc Res Tech. 1994. PMID: 7519903 Review.
Cited by
-
Increased differentiation capacity of bone marrow-derived mesenchymal stem cells in aquaporin-5 deficiency.Stem Cells Dev. 2012 Sep 1;21(13):2495-507. doi: 10.1089/scd.2011.0597. Epub 2012 Apr 20. Stem Cells Dev. 2012. PMID: 22420587 Free PMC article.
-
Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14982-7. doi: 10.1073/pnas.232570999. Epub 2002 Oct 28. Proc Natl Acad Sci U S A. 2002. PMID: 12403825 Free PMC article.
-
Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes.Cells. 2021 Dec 31;11(1):129. doi: 10.3390/cells11010129. Cells. 2021. PMID: 35011691 Free PMC article.
-
Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses.Mol Ther Methods Clin Dev. 2018 Jun 18;10:8-16. doi: 10.1016/j.omtm.2018.05.002. eCollection 2018 Sep 21. Mol Ther Methods Clin Dev. 2018. PMID: 29942826 Free PMC article.
-
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II.Br J Pharmacol. 2010 Mar;159(5):1082-91. doi: 10.1111/j.1476-5381.2009.00565.x. Epub 2010 Feb 5. Br J Pharmacol. 2010. PMID: 20136838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources